Loading clinical trials...
Loading clinical trials...
A Preliminary Exploratory Clinical Study of TC-D101 in the Treatment of DLL3-Positive Relapsed/Refractory Primary Small Cell Lung Cancer
Conditions
Interventions
TC-D101 CAR-T
Locations
1
China
The Jinling Hospital
Nanjing, Jiangsu, China
Start Date
November 30, 2025
Primary Completion Date
November 30, 2027
Completion Date
November 30, 2028
Last Updated
November 24, 2025
NCT04585750
NCT07198867
NCT05779917
NCT06333275
NCT07476287
NCT07206563
Lead Sponsor
TCRCure Biopharma Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions